Preferred Label : Tolcapone;
MeSH definition : A benzophenone and nitrophenol compound that acts as an inhibitor of CATECHOL O-METHYLTRANSFERASE,
an enzyme involved in the metabolism of DOPAMINE and LEVODOPA. It is used in the treatment
of PARKINSON DISEASE in patients for whom levodopa is ineffective or contraindicated.;
MeSH hyponym : Ro 40 7592; Ro 407592; Ro-40-7592; Ro407592;
Related MeSH term : 3,4 Dihydroxy 5' methyl 5 nitrobenzophenone;
MeSH CAS label : Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-;
MeSH Related Number : 134308-13-7 (Tolcapone);
UNII : CIF6334OLY;
Origin ID : D000077867;
UMLS CUI : C0246330;
ATC code(s)
ATC code(s)
Allowable qualifiers
MeSH indexing information
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
Validated automatic mappings to BTNT
A benzophenone and nitrophenol compound that acts as an inhibitor of CATECHOL O-METHYLTRANSFERASE,
an enzyme involved in the metabolism of DOPAMINE and LEVODOPA. It is used in the treatment
of PARKINSON DISEASE in patients for whom levodopa is ineffective or contraindicated.
https://ansm.sante.fr/tableau-marr/tolcapone
2025
false
false
false
France
French
risk management
continuity of patient care
Chemical and Drug Induced Liver Injury
neuroleptic malignant syndrome
Tolcapone
tolcapone
liver function tests
drug information
patient education handout
---
http://www.has-sante.fr/portail/jcms/c_2598650/fr/tasmar
http://www.has-sante.fr/portail/jcms/c_400726/fr/tasmar-100-mg-comprime-pellicule-flacon-s-en-verre-de-100-comprime-s-code-cip-345-466-4
2016
true
France
French
insurance, health, reimbursement
evaluation of the transparency committee
Catechol O-Methyltransferase Inhibitors
drug therapy, combination
parkinson disease
administration, oral
treatment outcome
tolcapone
Tolcapone
antiparkinson agents
benzophenones
nitrophenols
---
https://www.ema.europa.eu/medicines/human/EPAR/Tasmar
2012
false
United Kingdom
French
English
syndication feed
Catechol O-Methyltransferase Inhibitors
Catechol O-Methyltransferase Inhibitors
drug evaluation
drug therapy, combination
parkinson disease
tablets
administration, oral
treatment outcome
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug labeling
drug approval
tolcapone
drug evaluation
summary of product characteristics
package leaflet
Tolcapone
antiparkinson agents
antiparkinson agents
benzophenones
benzophenones
nitrophenols
benzophenones
nitrophenols
---
http://www.meddispar.fr/medicaments/3454664
2007
France
French
benzophenones
drug prescriptions
legislation, drug
continuity of patient care
nitrophenols
drug monitoring
tolcapone
drug information
Tolcapone
---